drug
atebimetinib
Phase 2updated 6mo agoby $IMRX Immuneering Corp
Phase 2community read0 votes
indications
indications
NSCLC
all catalysts(0)
nothing on the calendar yet
Trials studying atebimetinib
News(1)
- Novo submits sickle cell drug; Flagship, Gates Foundation deepen tiesNovo views the medicine, acquired in a billion-dollar deal, as a future blockbuster. Meanwhile, a pair of startups forged an RNA editing pact and Astellas lined up two new trials in pancreatic cancer.biopharma_dive · 3d ago
Data sources
last refreshed 4h ago
Found something off?
comments(0)
5-min edit window · permanent after that